<< Back U.S. CBD stakeholders cheer appointment of cannabis expert at FDA 88 0 System Admin / Wednesday, October 5, 2022 / Categories: HempToday.net CBD stakeholders say they hope the appointment of a cannabis policy expert at the U.S. Food & Drug Administration (FDA) signals the agency may finally... Read More Print 0Upvote 0Downvote Tags CBDPolicyRegulatoryNewsNorth AmericaUSALegislation Related articles German hemp company says it will diversify into vape device sales South Carolina bans CBD and intoxicating hemp products as states continue crackdowns Hempcrete seen as part of eco-friendly solution to Zimbabwe’s housing shortage Ahead for the industry: Fiber and food, sure, but hemp will be relegated to a ‘specialty crop’ U.S. CBD company inks sponsorship deal with professional baseball league << Back